unexplain
fever
one
common
difficult
diagnost
problem
face
daili
clinician
studi
evalu
differ
health
servic
util
health
care
expenditur
qualiti
care
provid
patient
unexplain
fever
global
budget
gb
implement
taiwan
nation
health
insur
research
databas
use
analyz
health
care
expenditur
qualiti
care
implement
gb
system
patient
diagnos
unexplain
fever
recruit
data
consid
baselin
postintervent
data
respect
data
patient
unexplain
fever
analyz
mean
length
stay
loss
gb
system
implement
day
day
respect
implement
mean
rate
revisit
emerg
depart
within
day
readmiss
within
day
increas
respect
implement
implement
gb
significantli
increas
lo
increment
total
cost
patient
unexplain
fever
improv
qualiti
care
abbrevi
bnhi
bureau
nation
health
insur
cmv
cytomegaloviru
ct
comput
tomographi
ed
emerg
depart
fdgpet
fluorodeoxyglucos
positron
emiss
tomographi
ff
feeforservic
fuo
fever
unknown
origin
gb
global
budget
hiv
human
immunodefici
viru
irb
institut
review
board
irr
incidencer
ratio
lo
length
stay
nhi
nation
health
insur
nhird
nation
health
insur
research
databas
nhri
nation
health
research
institut
sar
sever
acut
respiratori
syndrom
spect
singlephoton
emiss
comput
tomographi
tb
tuberculosi
unexplain
fever
repres
one
common
difficult
diagnost
problem
encount
daili
clinician
febril
ill
without
initi
obviou
etiolog
unexplain
fever
prolong
despit
intens
evalu
diagnost
test
clinician
refer
fever
unknown
origin
fuo
earlier
fuo
defin
fever
last
week
undiagnos
etiolog
even
week
intens
hospit
test
physician
special
infecti
diseas
redefin
fuo
fever
last
week
undiagnos
etiolog
day
inhospit
test
outpati
visit
pediatr
fuo
gener
accept
definit
fever
last
week
without
posit
preliminari
investig
without
diagnosi
three
outpati
clinic
visit
fuo
divid
follow
four
gener
categori
base
etiolog
fever
infect
rheumaticinflammatori
neoplast
miscellan
infecti
diseas
account
approxim
onethird
fuo
common
infect
associ
fuo
miliari
tuberculosi
tb
q
fever
brucellosi
follow
human
immunodefici
viru
hiv
cytomegaloviru
cmv
epsteinbarr
viru
intraabdomin
pelvic
intranephr
perinephr
abscess
typhoid
enter
fever
toxoplasmosi
extrapulmonari
tb
notabl
hiv
patient
fuo
result
secondari
infect
rather
hiv
infect
furthermor
rheumatolog
inflammatori
disord
rheumatoid
arthriti
system
lupu
erythematosu
giant
celltempor
arter
adult
still
diseas
periarter
nodosa
microscop
polyangi
account
anoth
onethird
fuo
moreov
fuo
due
neoplasm
malign
account
fuo
renal
cell
carcinoma
lymphoma
common
neoplasm
follow
acut
myeloid
leukemia
myeloprolif
disord
remain
caus
fuo
miscellan
disord
includ
drug
fever
liver
cirrhosi
crohn
diseas
subacut
thyroid
fuo
challeng
physician
diagnos
manag
current
repres
approxim
hospit
admiss
morbid
caus
prolong
hospit
stay
mortal
rate
account
furthermor
fuo
associ
repeat
invas
investig
presumpt
treatment
high
impact
health
care
system
due
unnecessari
addit
laboratori
test
medic
caus
fuo
report
rel
infecti
diseas
potenti
caus
prolong
fever
therefor
patient
prolong
perplex
fever
infect
rule
pose
diagnost
challeng
moreov
fever
one
common
reason
outpati
visit
children
visit
emerg
depart
ed
difficulti
diagnos
fuo
also
make
treatment
difficult
empir
antibiot
indic
unless
patient
fuo
neutropen
addit
empir
glucocorticoid
indic
without
strong
evid
rheumatolog
diseas
recurr
fuo
strong
independ
predictor
unestablish
diagnosi
repres
case
larg
seri
addit
final
diagnosi
establish
patient
recurr
fuo
comprehens
care
historytak
well
examin
physician
exhaust
laboratori
test
requir
focus
diagnost
evalu
fuo
diagnost
approach
fuo
includ
medic
historytak
physic
examin
laboratori
test
imag
studi
etiolog
fever
may
approach
term
height
fever
pattern
durat
studi
stress
signific
complet
histori
comprehens
physic
examin
case
infecti
fuo
fever
often
accompani
chill
night
sweat
weight
loss
without
loss
appetit
rigor
exud
tonsil
splenomegali
gener
longer
fuo
remain
undiagnos
like
noninfecti
etiolog
patient
present
bsymptom
signific
weight
loss
might
neoplasm
malign
caus
fuo
contrast
joint
involv
may
indic
rheumatolog
disord
laboratori
test
includ
complet
blood
count
three
set
blood
cultur
erythrocyt
sediment
rate
complet
metabol
panel
urinalysi
urin
cultur
tuberculin
skin
test
test
biomark
antinuclear
antibodi
rheumatoid
factor
cmv
immunoglobulin
hiv
antibodi
heterophil
antibodi
children
young
adult
moreov
imag
techniqu
includ
chest
radiographi
comput
tomographi
ct
radionuclid
scan
fuo
associ
broad
differenti
diagnosi
lead
wide
rang
potenti
diagnost
therapeut
cost
howev
littl
known
regard
hospit
cost
patient
fuo
recent
studi
report
high
hospit
charg
fuo
us
nation
health
insur
nhi
program
backbon
health
care
system
taiwan
major
sourc
health
financ
cover
popul
taiwan
nation
health
care
expenditur
taiwan
increas
gross
nation
product
nhi
oper
feeforservic
ff
basi
result
health
care
spend
increas
approxim
prevent
unlimit
rapid
growth
spend
health
care
bureau
nhi
bnhi
implement
global
budget
gb
system
modifi
ff
mechan
gb
taiwan
overal
spend
target
design
limit
volum
servic
total
price
evalu
differ
health
servic
util
health
care
expenditur
qualiti
care
among
patient
unexplain
fever
gb
system
implement
use
nhi
research
databas
nhird
data
prepost
comparison
studi
studi
base
part
data
nhird
provid
bnhi
depart
health
manag
nation
health
research
institut
nhri
databas
contain
registr
file
origin
claim
data
reimburs
nhird
provid
scientist
taiwan
research
purpos
year
bnhi
collect
data
nhi
program
sort
data
file
data
file
deidentifi
scrambl
identif
code
patient
medic
facil
sent
nhri
form
origin
file
contain
nhird
base
registr
file
origin
claim
data
nhird
specif
data
subset
reconstruct
research
purpos
registr
dataset
system
sampl
inpati
expenditur
admiss
dd
file
system
sampl
ambulatori
care
expenditur
visit
cd
file
use
studi
interpret
conclus
contain
herein
repres
bnhi
depart
health
nhri
system
sampl
cd
dd
file
ambulatori
care
expenditur
visit
cd
file
extract
systemat
sampl
method
monthli
basi
togeth
relat
record
detail
ambulatori
care
order
form
systemat
sampl
cd
file
inpati
expenditur
admiss
dd
file
extract
systemat
sampl
method
monthli
basi
togeth
relat
record
detail
inpati
order
form
systemat
sampl
dd
file
total
one
million
case
system
sampl
dataset
use
studi
taiwan
report
sar
impact
health
care
util
therefor
data
use
studi
score
ad
subject
comorbid
myocardi
infarct
congest
heart
failur
peripher
vascular
diseas
cerebrovascular
diseas
dementia
chronic
pulmonari
diseas
connect
tissu
diseas
peptic
ulcer
diseas
mild
liver
diseas
diabet
without
endorgan
damag
score
ad
subject
comorbid
hemiplegia
moder
sever
renal
diseas
diabet
endorgan
damag
tumor
without
metastas
leukemia
lymphoma
score
ad
subject
comorbid
moder
sever
liver
diseas
score
ad
subject
comorbid
metastat
solid
tumor
acquir
immunodefici
syndrom
total
score
obtain
ad
rel
weight
comorbid
decad
year
age
score
ad
sum
abovement
score
taiwan
health
insur
premium
calcul
percentag
individu
monthli
salari
seven
incom
level
studi
level
tabl
http
link
nhird
encrypt
patient
person
inform
protect
privaci
provid
research
anonym
identif
number
associ
relev
claim
inform
includ
sex
date
birth
medic
servic
receiv
prescript
patient
consent
requir
access
nhird
studi
approv
institut
review
board
irb
china
medic
univers
irb
specif
waiv
consent
requir
data
relat
metadata
deposit
appropri
public
repositori
data
studi
popul
obtain
nhird
http
maintain
nhird
http
nhirdnhri
orgtw
nhri
nonprofit
foundat
establish
govern
data
describ
mean
standard
deviat
test
use
compar
differ
mean
valu
multilevel
gener
linear
model
employ
determin
impact
sever
independ
variabl
multilevel
gener
linear
model
employ
determin
impact
sever
independ
variabl
lo
diagnost
cost
drug
cost
therapi
cost
total
cost
risk
revisit
ed
within
day
risk
readmit
within
day
discharg
two
nest
level
studi
hospit
accredit
level
region
level
three
accredit
hospit
level
taiwan
medic
center
region
hospit
local
hospit
taiwan
divid
six
geograph
area
includ
taipei
citi
northern
taiwan
central
taiwan
southern
taiwan
kaoshiung
eastern
taiwan
independ
variabl
evalu
studi
includ
prepost
gb
age
gender
incom
state
index
charlson
comorbid
index
three
hospit
level
six
geograph
area
taiwan
statist
analys
perform
use
statist
packag
stata
window
version
pvalu
consid
repres
statist
signific
data
patient
unexplain
fever
preand
postgb
analyz
studi
mean
age
subject
gb
year
year
respect
prebudget
group
subject
male
postbudget
group
subject
male
mean
incom
state
index
gb
respect
mean
charlson
comorbid
index
gb
respect
signific
differ
age
male
femal
ratio
incom
state
index
implement
gb
system
p
p
p
howev
signific
differ
charlson
comorbid
index
gb
p
tabl
mean
lo
adopt
gb
day
mean
lo
implement
system
day
mean
diagnost
cost
gb
system
went
effect
nt
nt
respect
mean
drug
cost
increas
nt
baselin
nt
adopt
gb
system
mean
therapi
cost
gb
nt
nt
respect
mean
total
cost
increas
nt
baselin
nt
system
went
effect
mean
ed
revisit
rate
decreas
baselin
adopt
gb
system
mean
readmiss
rate
gb
respect
signific
differ
lo
diagnost
cost
therapi
cost
total
cost
ed
revisit
rate
readmiss
rate
implement
gb
system
among
patient
wwwmdjournalcom
unexplain
fever
p
p
p
p
p
p
respect
signific
differ
drug
cost
gb
among
patient
unexplain
fever
p
tabl
gener
linear
poisson
model
use
cluster
count
data
analysi
poisson
regress
model
fit
use
option
irr
incidencer
ratio
obtain
exponenti
estim
gb
system
signific
impact
lo
irr
p
addit
gender
signific
predictor
lo
irr
p
significantli
posit
correl
age
charlson
comorbid
index
lo
irr
p
irr
p
respect
signific
correl
incom
state
index
lo
irr
p
lo
differ
significantli
patient
treat
medic
center
treat
local
hospit
irr
p
howev
patient
treat
region
hospit
significantli
shorter
lo
treat
medic
center
irr
p
compar
hospit
taipei
tabl
gener
linear
model
use
analysi
diagnost
cost
skew
right
data
convert
log
base
statist
analysi
gb
system
significantli
posit
impact
diagnost
cost
b
p
neither
gender
incom
state
index
significantli
correl
diagnost
cost
b
p
b
p
respect
significantli
neg
correl
age
diagnost
cost
b
p
significantli
posit
correl
charlson
comorbid
index
diagnost
cost
b
p
signific
differ
diagnost
cost
region
hospit
medic
center
local
hospit
medic
center
b
p
b
p
respect
compar
hospit
taipei
citi
signific
differ
diagnost
cost
among
hospit
locat
northern
taiwan
central
taiwan
southern
taiwan
kaoshiung
citi
eastern
taiwan
b
p
b
p
b
p
b
p
b
p
respect
tabl
taiwan
tabl
impact
sever
independ
variabl
lo
patient
unexplain
fever
gener
linear
poisson
model
gener
linear
model
use
analysi
drug
cost
skew
right
data
convert
log
base
statist
analysi
gb
significantli
neg
impact
drug
cost
b
p
significantli
posit
correl
age
drug
cost
b
p
signific
correl
gender
incom
state
index
charlson
comorbid
index
drug
cost
b
p
b
p
b
p
respect
signific
differ
drug
cost
region
hospit
medic
center
local
hospit
medic
center
b
p
b
p
respect
compar
hospit
taipei
citi
signific
differ
drug
cost
among
hospit
northern
taiwan
central
taiwan
southern
taiwan
kaoshiung
citi
eastern
taiwan
b
p
b
p
b
p
b
p
b
p
respect
tabl
gener
linear
model
use
analysi
therapi
cost
skew
right
data
convert
log
base
statist
analysi
gb
significantli
posit
impact
therapi
cost
b
p
signific
correl
gender
incom
state
index
therapi
cost
b
p
b
p
respect
significantli
neg
correl
age
therapi
cost
b
p
significantli
posit
correl
charlson
comorbid
index
therapi
cost
b
p
signific
differ
therapi
cost
region
hospit
medic
center
local
hospit
medic
center
b
p
b
p
respect
compar
hospit
taipei
citi
signific
differ
therapi
cost
among
hospit
northern
taiwan
central
taiwan
southern
taiwan
kaoshiung
citi
eastern
taiwan
b
p
b
p
b
p
b
p
b
p
respect
tabl
gener
linear
model
use
analysi
total
cost
skew
right
data
convert
log
base
statist
analysi
gb
significantli
posit
impact
total
cost
b
p
signific
correl
gender
age
incom
state
index
total
cost
b
p
b
p
b
p
respect
significantli
posit
correl
charlson
comorbid
index
total
cost
b
p
signific
differ
total
cost
region
hospit
medic
center
local
hospit
medic
center
b
p
b
p
respect
compar
hospit
taipei
citi
signific
differ
total
cost
among
hospit
northern
taiwan
central
taiwan
southern
taiwan
kaoshiung
citi
eastern
taiwan
b
p
b
p
b
p
b
p
b
p
respect
tabl
tabl
impact
sever
independ
variabl
diagnost
cost
drug
cost
therapi
cost
patient
unexplain
fever
gener
linear
model
tabl
impact
sever
independ
variabl
total
cost
patient
unexplain
fever
gener
linear
model
gener
linear
binari
regress
model
use
analysi
gb
signific
impact
risk
revisit
ed
within
day
p
signific
correl
age
gender
incom
state
index
charlson
comorbid
index
risk
revisit
ed
within
day
p
p
p
p
respect
addit
signific
differ
risk
revisit
ed
within
day
region
hospit
medic
center
local
hospit
medic
center
p
p
respect
compar
hospit
taipei
citi
signific
differ
risk
revisit
ed
within
day
among
hospit
northern
taiwan
central
taiwan
southern
taiwan
kaoshiung
citi
eastern
taiwan
p
p
p
p
p
respect
tabl
gener
linear
binari
regress
model
use
analysi
gb
signific
impact
risk
readmit
within
day
p
signific
correl
age
gender
incom
state
index
charlson
comorbid
index
risk
readmiss
within
day
p
p
p
p
respect
signific
differ
risk
readmiss
within
day
note
region
hospit
medic
center
local
hospit
medic
center
p
p
respect
compar
hospit
taipei
citi
signific
differ
risk
readmit
within
day
among
hospit
northern
taiwan
central
taiwan
southern
taiwan
kaoshiung
citi
eastern
taiwan
p
p
p
p
p
respect
tabl
unexplain
fever
impos
addit
burden
nhi
system
patient
howev
studi
hospit
cost
patient
unexplain
fever
limit
studi
investig
impact
gb
system
patient
unexplain
fever
taiwan
gb
system
associ
significantli
longer
lo
patient
unexplain
fever
adjust
covari
age
charlson
comorbid
index
independ
lo
predictor
gb
significantli
affect
lo
patient
unexplain
fever
patient
unexplain
fever
region
hospit
significantli
shorter
lo
patient
medic
center
fuo
diagnos
less
frequent
adult
children
howev
adult
patient
like
admit
longer
loss
mean
age
patient
unexplain
fever
medic
center
year
wherea
patient
idiopath
fever
region
hospit
year
mean
charlson
comorbid
index
medic
center
region
hospit
respect
thu
younger
age
fewer
comorbid
shorter
may
loss
patient
unexplain
fever
region
hospit
infect
main
caus
fuo
children
includ
children
taiwan
notabl
signific
proport
pediatr
patient
account
approxim
remain
undiagnos
howev
adult
number
undiagnos
case
demonstr
common
infecti
etiolog
case
fluorodeoxyglucos
positron
emiss
tomographi
fdgpet
ct
emerg
end
centuri
appli
diagnosi
fuo
compar
convent
scintigraph
techniqu
fdgpetct
follow
advantag
higher
resolut
higher
sensit
anatom
local
infecti
inflammatori
neoplast
process
workup
patient
fuo
demonstr
diagnost
perform
ffdgpetct
superior
ga
singlephoton
emiss
comput
tomographi
spect
ct
furthermor
previou
studi
suggest
use
fdgpet
ct
shorten
diagnost
workup
fuo
metaanalysi
report
pet
petct
success
local
sourc
fever
patient
classic
fuo
respect
seri
unsuccess
investig
major
drawback
cost
access
fdgpetct
cost
compar
chestabdomenpelvi
tabl
impact
sever
independ
variabl
risk
revisit
ed
within
day
risk
readmiss
within
day
among
patient
unexplain
fever
gener
binari
linear
model
risk
readmiss
within
day
ct
howev
could
offset
earlier
definit
treatment
due
higher
diagnost
sensit
could
reduc
lo
averag
per
day
therefor
fdgpetct
aid
diagnos
fuo
particularli
diagnost
clue
absent
diagnost
therapi
total
cost
incur
treat
patient
unexplain
fever
significantli
increas
gb
system
implement
adjust
covari
gb
system
charlson
comorbid
index
found
posit
correl
increas
diagnost
therapi
total
cost
increas
health
care
expenditur
significantli
exceed
growth
consum
price
index
period
taiwan
tabl
http
link
possibl
reason
higher
cost
includ
longer
loss
addit
comorbid
higher
proport
older
individu
studi
popul
gb
system
implement
tabl
moreov
salari
physician
taiwan
calcul
less
basi
ff
therefor
physician
demonstr
natur
procliv
maxim
medic
servic
maxim
incom
gb
system
provid
incent
physician
reduc
volum
medic
care
health
care
expenditur
incur
patient
unexplain
fever
differ
hospit
differ
accredit
level
differ
geograph
area
taiwan
risk
revisit
ed
within
day
readmiss
within
day
significantli
decreas
implement
gb
system
suggest
qualiti
care
improv
howev
control
covari
gb
associ
reduc
risk
revisit
ed
within
day
readmiss
within
day
furthermor
none
test
variabl
independ
predictor
revisit
ed
within
day
readmit
within
day
patient
unexplain
fever
possibl
reason
observ
regul
evalu
qualiti
care
hospit
taiwan
bnhi
develop
seri
plan
structur
improv
qualiti
care
keep
cost
control
plan
offer
incent
health
care
provid
pay
base
clinic
outcom
care
overal
wellb
patient
risk
revisit
ed
within
day
readmiss
within
day
two
indic
use
bnhi
measur
qualiti
care
two
indic
link
reimburs
rate
hospit
amount
reimburs
reduc
qualiti
care
determin
poor
safeguard
penal
hospit
taiwan
made
concert
effort
reduc
ed
revisit
readmiss
rate
studi
differ
risk
revisit
ed
within
day
readmiss
within
day
hospit
differ
accredit
level
differ
geograph
area
taiwan
note
research
limit
first
nhird
data
provid
detail
inform
patient
regard
factor
lifestyl
habit
socioeconom
statu
famili
histori
possibl
confound
factor
studi
second
nhi
claim
registri
primarili
use
administr
bill
alon
thu
verifi
scientif
purpos
laboratori
data
inform
regard
symptom
patient
lack
therefor
discuss
factor
relat
gb
system
possibl
furthermor
anonym
identif
number
obtain
addit
inform
directli
contact
patient
possibl
accuraci
medic
code
claim
data
may
affect
data
valid
howev
diagnosi
data
nhird
highli
reliabl
insur
system
mechan
monitor
insur
claim
third
conclus
deriv
cohort
studi
gener
lower
methodolog
qualiti
random
trial
cohort
studi
subject
sever
bias
necessari
adjust
confound
factor
requir
despit
meticul
design
studi
adequ
control
confound
factor
bias
associ
possibl
unmeasur
unknown
confound
factor
occur
gb
significantli
increas
lo
increment
diagnost
therapeut
total
cost
howev
qualiti
care
improv
patient
unexplain
fever
similar
health
polici
appli
countri
benefit
patient
unexplain
fever
tabl
age
stratif
unexplain
fever
patient
implement
global
budget
gb
post
gb
